Concepedia

Publication | Open Access

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)

DOIFull Paper Access

38

Citations

26

References

2014

Year

Ayoub Charehbili, Saskia van de Ven, Vincent T.H.B.M. Smit, Elma Meershoek‐Klein Kranenbarg, N.A.T. Hamdy, Hein Putter, Joan B. Heijns, L.J.C. van Warmerdam, Lonneke W. Kessels, M. Wouter Dercksen,
Annals of Oncology

References

YearCitations

Page 1